修改的库里和SIOPEN骨评分系统在F-AlF-NOTA-octreotide PET/CT中用于神经母细胞瘤的应用

Siqi Li1, Baojun Sang2, Jun Liu1

  • 1Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.

Annals of nuclear medicine
|December 14, 2024
PubMed
概括

-18-化-1,4,7-triazacyclononane-1,4,7-triacetic acid-octreotide (18F-OC) PET/CT检测到的神经母细胞瘤病变比-123 MIBG光学扫描更多. 修改后的库里评分系统是可行的半量化疾病的程度与18F-OC PET/CT.